Etoricoxib Impurity 30 | CAS 221615-72-1 - Request Quote
Etoricoxib Impurity 30
| SZ CAT No: | SZ-E030039 |
| CAS No | 221615-72-1 |
| Mol.F. | C15H15NOS |
| Mol.Wt. | 257.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Etoricoxib Impurity 30 is chemically 1-(6-Methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethan-1-one. Etoricoxib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Etoricoxib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etoricoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 221615-72-1
Purchase 221615-72-1
Order 221615-72-1
Enquire 221615-72-1
price of 221615-72-1
221615-72-1 Supplier
221615-72-1 Manufacturer
221615-72-1 Exporter
buy high quality Etoricoxib Impurity 30
Purchase Etoricoxib Impurity 30
Etoricoxib Impurity 30 suppliers
Etoricoxib Impurity 30 manufacturers
Etoricoxib Impurity 30 price
Order Etoricoxib Impurity 30
Enquire Etoricoxib Impurity 30
Etoricoxib Impurity 30 cost
Etoricoxib Impurity 30 Supplier
Etoricoxib Impurity 30 Distributor
Etoricoxib Impurity 30 for Method Validation
Etoricoxib Reference Standard
Etoricoxib Impurity 30 for ANDA Filing
Etoricoxib Impurity 30 for Forced Degradation Studies
Etoricoxib Impurity 30 Identification Standards
Etoricoxib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.